SCHEMBL4576216

SCHEMBL4576216

CC(C)(Oc1ccc(CCN(Cc2ccc(-c3noc(C4CC4)n3)cc2)c2noc(-c3ccc(Cl)cc3)n2)cc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
PKM P14618 1/20 0.40
PPARA Q07869 7/20 0.40
PPARD Q03181 4/20 0.40
PPARG P37231 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
FABP2 P12104 1/20 0.40
FFAR1 O14842 2/20 0.40
FABP1 P07148 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
S1PR1 P21453 3/20 0.38
S1PR5 Q9H228 3/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4598247 0.94 PPARA (0.43) ALDH1A1KDM4EPPARAPPARDPPARG
SCHEMBL4575126 0.93 TUBB4A (0.41) ALDH1A1PPARAPPARDPPARGSMN1; SMN2
SCHEMBL4574848 0.93 LMNA (0.43) MEN1KMT2AALDH1A1PPARAPPARD
SCHEMBL4575133 0.92 FABP1 (0.40) PPARAPPARDPPARGFFAR1FABP1
SCHEMBL4575966 0.92 FABP1 (0.40) ALDH1A1PPARAPPARDPPARGFABP1
SCHEMBL4576160 0.92 PPARA (0.44) ALDH1A1PPARAPPARDPPARGFFAR1
SCHEMBL4575831 0.91 PPARA (0.43) PPARAPPARDPPARGSMN1; SMN2FFAR1
SCHEMBL4575172 0.89 ALDH1A1 (0.44) MEN1KMT2AALDH1A1KDM4EPPARA
SCHEMBL4575858 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EPPARAPPARDPPARG
SCHEMBL4575732 0.89 PPARA (0.43) ALDH1A1PPARAPPARDPPARGFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD MEN1 4576/4885TP53 1380/4885KMT2A 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.